10.1002/chem.201905505
Chemistry - A European Journal
FULL PAPER
overdose mortality, United Nations, 2013. b) G. Willyard, Mitigating
opioids’ harm, Nature 2019, 573, S17-S19.
Edwards, R. I. Robinson, I. R. Clemens, B. Cox, D. D. Pascoe, Chem.–
Eur. J. 2014, 20, 15226-15232. e) E. M. Schuster, P. Wipf, Isr. J. Chem.
2014, 54, 361-370.
[5]
[6]
M. S. Sadove, R. C. Balagot, S. Hatano, E. A. Jobgen, J. Am. Med.
Assoc.1963, 183, 666–668.
[25] C. A. Hone, D. Roberge, C. O. Kappe, ChemSusChem 2017, 10, 32-41.
[26] T. Y. Shang, L. H. Lu, Z. Cao, Y. Liu, W. M. He, B. Yu, Chem. Commun.
2019, 55, 5408−5419.
a) A. K. Clark, C. M. Wilder, E. L. Winstanley, J. Addict. Med. 2014, 8,
153-163; b) J. M. Chamberlain, B. L. Klein, Am. J. Emerg. Med.1994,
12, 650-660.
[27] A. P. Darmanyan, Chem. Phys. Lett. 1984, 110, 89−94.
[28] R. C. Kanner, C. S. Foote, J. Am. Chem. Soc. 1992, 114, 678-681.
[29] a) N. A. Romero, D. A. Nicewicz, Chem. Rev. 2016, 116, 10075-10166.
b) M. H. Shaw, J. Twilton, D. W. C. MacMillan, J. Org. Chem. 2016, 81,
6898-6926. c) J. W. Tucker, C. R. J. Stephenson, J. Org. Chem. 2012,
77, 1617-1622.
[7]
[8]
World Health Organization, World Health Organization Model List of
Essential Medicines, 21st List, United Nations, 2019.
For the synthesis of Naloxone form oripavine, see: a) R. J. Kupper, U.S.
Patent No. 7,939,543. 10 May, 2011. b) J. R. Giguere,; H. A. Reisch, S.
Sandoval, J. L. Stymiest, U.S. Patent No. 8,921,556. 30 Dec. 2014.
a) J. D. Phillipson, A. Scutt, A. Baytop, N. Özhatay, G. Sariyar, Planta
Medica 1981, 43, 261-271. b) A. Coop, J. W. Lewis, K. C. Rice, J. Org.
Chem. 1996, 61, 6774-6774.
[9]
[30] C. J. Clarke, W.-C. Tu, O. Levers, A. Bröhl, J. P. Hallett, Chem.
Rev. 2018, 118, 747-800.
[31] Y. Chen, O. de Frutos, C. Mateos, J. A. Rincon, D. Cantillo, C. O.
Kappe, ChemPhotoChem 2018, 2, 906-912.
[10] For the synthesis of Naloxone from thebaine, see: a) Z. Fang, J. Wang,
W. Jiang, L. Zhang, R. Yu, D. Zhao, CN 104230945 A, Dec 24, 2014. b)
Y. Zheng, M. Lu, X. Wang, W. Sheng, Z. Qiu, Fudan Xuebao, Yixueban
2007, 34, 888-890. c) J. Cardot, W.-C. Zhang, U.S. Patent No.
9,701,687. 11 Jul. 2017. d) M. Conza, V. Lellek, H. Zinser. U.S. Patent
No. 9,701,688. 11 Jul. 2017.
[32] This work was carried out with a 2.77 mL reactor. It should be noted
that the commercial platform utilized can be readily scaled up even for
gas liquid mixtures by simply using larger volume plates: N. Emmanuel,
C. Mendoza, M. Winter, Horn, C. A. Vizza, L. Dreesen, B. Heinrichs, J.-
C. M. Monbaliu, Org. Process Res. Dev. 2017, 21, 1435-1438.
…
[11] L. Werner, M. Wernerova, A. Machara, M. A. Endoma-Arias, J. Duchek,
D. R. Adams, D. P. Cox, T. Hudlický, Adv. Synth. Catal. 2012, 354,
2706-2712.
[12] S. Thavaneswaran, K. McCamley, P. J. Scammells, Nat. Prod.
Commun. 2006, 1, 885–897.
[13] For the N-demethlyation using chloroformate, see: a) A. Kimishima, C.
J. Wenthur, B. Zhou, K. D. Janda, ACS Chem. Biol. 2016, 12, 36-0. b)
R. A. Olofson, J. T. Martz, J. P. Senet, M. Piteau, T. Malfroot, J. Org.
Chem.1984, 49, 2081-2082. c) M. A. Schwartz, R. A. Wallace, J. Med.
Chem.1981, 24, 1525-1528.
[14] For the N-demethlyation using BrCN, see: a) A. Machara, M. A. A.
Endoma-Arias, I. Císařova, D. P. Cox, T. Hudlický, Synthesis, 2016, 48,
1803-1813. b) B. R. Selfridge, X. Wang, Y. Zhang, H. Yin, P. M. Grace,
L. R. Watkins, A. E. Jacobson, K. C. Rice, J. Med. Chem. 2015, 58,
5038-5052.
[15] For the N-demethlyation using H2O2, see: a) D. D. Do Pham, G. F.
Kelso, Y. Yang, M. T. Hearn, Green Chem. 2014, 16, 1399-1409. b) G.
B. Kok, P. J. Scammells, Bioorg. Med. Chem. Lett. 2010, 20, 4499-
4502. c) Z. Dong, P. J. Scammells, J. Org. Chem. 2007, 72, 9881-9885.
d) K. McCamley, J. A. Ripper, R. D. Singer, P. J. Scammells, J. Org.
Chem. 2003, 68, 9847-9850.
[16] For the N-demethlyation using O2 and Pd, see: a) R. J. Carroll, H.
Leisch, E. Scocchera, T. Hudlicky, D. P. Cox, Adv. Synth. Catal. 2008,
350, 2984-2992. b) A. Machara, L. Werner, M. A. Endoma-Arias, D. P.
Cox, T. Hudlický, Adv. Synth. Catal. 2012, 354, 613-626.
[17] A. Machara, D. P. Cox, T. Hudlicky, Adv. Synth. Catal. 2012, 354,
2713-2718.
[18] Gutmann, B.; Weigl, U.; Cox, D. P.; Kappe, C. O. Batch‐and
Continuous‐Flow Aerobic Oxidation of 14‐Hydroxy Opioids to 1, 3‐
Oxazolidines—A Concise Synthesis of Noroxymorphone. Chem.—Eur.
J. 2016, 22, 10393−10398.
[19] B. Gutmann, D. Cantillo, U. Weigl, D. P. Cox, C. O. Kappe, Eur. J. Org.
Chem. 2017, 914-927.
[20] B. Gutmann, P. Elsner, D. P. Cox, U. Weigl, D. M. Roberge, C. O.
Kappe, ACS Sustain. Chem. Eng. 2016, 4, 6048-6061.
[21] J. A. Ripper, E. R. Tiekink, P. J. Scammells, Bioorg. Med. Chem. Lett.
2001, 11, 443-445.
[22] a) J. W. Beatty, C. R. Stephenson, Acc. Chem. Res. 2015, 48, 1474-
1484. b) G. Wu, Y. Li, X. Yu, Y. Gao, H. Chen, Adv. Synth. Catal. 2017,
359, 687-692.
[23] a) P. Sobieszuk, J. Aubin, R. Pohorecki, Chem. Eng. Techn. 2012, 35,
1346-1358. b) G. N. Doku, W. Verboom, D. N. Reinhoudt, A. van den
Berg, Tetrahedron 2005, 61, 2733−2742.
[24] a) D. Cambie, C. Bottecchia, N. J. Straathof, V. Hessel, T. Noël, Chem.
Rev. 2016, 116, 10276-10341. b) Y. Su, N. J. Straathof, V. Hessel, T.
Noël, Chem.–Eur. J. 2014, 20, 10562-10589. c) K. Gilmore, P. H.
Seeberger, Chem. Rec. 2014, 14, 410-418. d) L. D. Elliott, J. P.
Knowles, P. J. Koovits, K. G. Maskill, M. J. Ralph, G. Lejeune, L. J.
7
This article is protected by copyright. All rights reserved.